Response to “Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up ” Haematologica 2014;99(2):e17–18.

Lignende værker

• Reply to “The challenge of cross-trial comparison using limited data” Haematologica. 2014;99(8):e000
  af: Siegel, David S.
  Udgivet: (2014)
• Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up
  af: Derchi, Giorgio, et al.
  Udgivet: (2014)
• Reply to “Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated cases”. Haematologica 2014;99(2):e20–21.
  af: Mendler, Jason H., et al.
  Udgivet: (2014)
• Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension
  af: Morris, Claudia R., et al.
  Udgivet: (2013)
• Newborn Screening for Hemoglobinopathies in California
  af: Michlitsch, Jennifer, et al.
  Udgivet: (2009)